Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

13.68
Delayed Data
As of May 27
 +0.22 / +1.63%
Today’s Change
6.91
Today|||52-Week Range
15.79
+2.78%
Year-to-Date
3 Biotech Stocks to Buy in June
May 27 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close13.46
Today’s open13.42
Day’s range13.28 - 13.68
Volume437,425
Average volume (3 months)728,575
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+96.24%
Earnings growth (this year)-2,845.71%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+468.89%
P/E ratioNM
Price/Sales10.61
Price/Book4.96

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc+0.04+0.63%
ABCOAdvisory Board Co-0.08-0.25%
ARIAARIAD Pharmaceutical...+0.18+2.24%
DBVTDBV Technologies SA+0.29+0.90%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$130.0M
Annual profit (last year)-$4.7M
Net profit margin-3.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
VP-Marketing, Commercial Strategy &
Operations
John Northcott
Corporate headquarters
The Woodlands, Texas

Forecasts

Partner Offers

Search for Jobs